Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2007
12/06/2007WO2007075872A3 Nitroimidazole compounds
12/06/2007WO2007075186A3 Antimicrobial therapy for bacterial infections
12/06/2007WO2007072992A3 Solid preparation containing an insulin sensitizer
12/06/2007WO2007070703A3 Sinomenine derivatives and preparation and uses thereof
12/06/2007WO2007064861A3 Asymmetric friedel-crafts alkylations catalyzed by byfunctional cinchona alkaloids
12/06/2007WO2007063356A3 Derivatives of pentose monosaccharides as anti-inflammatory compounds
12/06/2007WO2007061737A3 FUSED BICYCLIC mTOR INHIBITORS
12/06/2007WO2007061695A3 Bicyclic spirohydantoin cgrp receptor antagonists
12/06/2007WO2007061694A3 Spirohydantoin tricyclic cgrp receptor antagonists
12/06/2007WO2007060518A3 Ketolide derivatives as antibacterial agents
12/06/2007WO2007058990A3 Therapy using cytokine inhibitors
12/06/2007WO2007056543A3 Relaxase modulators and methods of using same
12/06/2007WO2007056221A3 Aminopyrimidines useful as kinase inhibitors
12/06/2007WO2007055890A3 Co-administration of dehydroepiandrosterone (dhea) congeners and other active agents for treating cancer
12/06/2007WO2007055773A3 Use of inhibitors of pi3k-c2a for the treatment of apoptos i s-related disorders
12/06/2007WO2007048080A3 Stable pharmaceutical formulations containing escitalopram and bupropion
12/06/2007WO2007042885A3 Therapeutic combination comprising methotrexate and a specified inhibitor of mek1 and mek2
12/06/2007WO2007041278B1 Composition and methods for stimulating gastrointestinal motility
12/06/2007WO2007039919A8 Crystalline forms of anastrozole
12/06/2007WO2007038466A3 Treatment of bipolar disorder utilizing anti-fungal compositions
12/06/2007WO2007038112A3 Combination of rosiglitazone and donepezil for improvement of cognitive function
12/06/2007WO2007034489A3 Immunogenic fragments of t-cell receptor constant domains and peptides derived therefrom
12/06/2007WO2007033356B1 Compositions and methods for green tea catechins for modification of detoxification enzymes
12/06/2007WO2007025212A3 Use of sodium channel blockers for the treatment of visceral pain or pain caused by cancer treatment
12/06/2007WO2007025187A3 Compounds and methods for modulating the silencing of a polynucleotide of interest
12/06/2007WO2007025064A3 METHODS OF USING SELECTIVE llβ-HSD INHIBITORS TO TREAT GLUOCORTICOID ASSOCIATED STATES
12/06/2007WO2007022344A3 Methods and compositions for the preventioin and treatment of kidney disease
12/06/2007WO2007022307A3 Ligands for metal ions and methods for making and using the same
12/06/2007WO2007016580A3 Silencing rna molecules and their use in bone formation
12/06/2007WO2007001926A3 Low-swelling hydrogel sealants for wound repair
12/06/2007WO2006122183A3 Injectable hydrogels and methods of making and using same
12/06/2007WO2006118953A3 Method of treating multiple myeloma using 17-aag of 17-ag of a prodrug of either
12/06/2007WO2006110763A9 Pyrimidine derivatives and their use for the treatment of cancer
12/06/2007WO2006107825A3 Skin enrichment using coq10 as the delivery system
12/06/2007WO2006106427A8 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
12/06/2007WO2006104668A3 Composition and methods for the treatment of proliferative diseases
12/06/2007WO2006102483A3 Modulation of aquaporin in modulaton of angiogenesis and cell migration
12/06/2007WO2006083653A3 Systems and methods for delivery of peritoneal dialysis (pd) solutions
12/06/2007WO2006076655A3 Use of alpha-2 adrenergic receptor agonists
12/06/2007WO2006072070A3 Pharmaceutical formulations of gallium salts
12/06/2007WO2006067428A3 1, 2-diphenyl-imidazole derivatives and their use as cb1 receptor ligands
12/06/2007WO2006044342A3 Self-gelling alginate systems and uses thereof
12/06/2007WO2006003654A3 Methods and kits for predicting liver fibrosis progression rate in chronic hepatitis c patients
12/06/2007WO2005069865A3 Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
12/06/2007WO2005033277A3 Methods of modulating cell cycle and cell signaling pathways using biliverdin reductase
12/06/2007WO2005022118A3 Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics
12/06/2007WO2005017493A3 Biomarkers in cancer
12/06/2007WO2004093664A3 Method and kit for controlling bleeding
12/06/2007WO2004028342A3 Endogenous granzyme b in human non-hematopoietic cells
12/06/2007US20070282261 Telescoping perfusion management system
12/06/2007US20070282260 Telescoping perfusion management system
12/06/2007US20070282126 Novel Crystal Of Triterpene Derivative
12/06/2007US20070282108 preparing 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone (cilostazol) by reacting 6-hydroxy-3,4-dihydroquinoline-2(1H)-one and 5-(4-chlorobutyl)-1-cyclohexyl-1H-tetrazole in an aqueous single phase
12/06/2007US20070282105 e.g. 3-[2-(4-aminophenyl)ethyl]-8-benzyl-7-(2-ethylamino)ethyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility
12/06/2007US20070282100 Boronic ester and acid compounds, synthesis and uses
12/06/2007US20070282017 Methods and compositions for treating and preventing neurologic disorders
12/06/2007US20070282014 Hydroxyethylstarch
12/06/2007US20070282012 Reagent for Lacrimation Examination and Method of Lacrimation Examination
12/06/2007US20070282011 Biodegradable water soluble polymers
12/06/2007US20070282010 Methods of Accelerating Muscle Growth, Decreasing Fat Deposits and Improving Feed Efficiency in Livestock Animals
12/06/2007US20070282009 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
12/06/2007US20070282008 Antimicrobial Compositions and Methods for Their Use
12/06/2007US20070282007 TREATMENT OF PAIN DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE AND ITS FORMAMIDE
12/06/2007US20070282006 Method of enhancing hair growth
12/06/2007US20070282005 Hmgb1 expression and protective role of semapimod in nec
12/06/2007US20070282004 Use of a Cyclopentenone Prostaglandin for Delaying for the Onset and/or Preventing the Continuation of Labour
12/06/2007US20070282003 Compounds for the Treatment of Metabolic Disorders
12/06/2007US20070282002 N-lauroyl-L-valine, as therapeutic agent of metabolic syndromes, hypoadiponectinemia, hyperlipemia, diabetes, hypertension, cardiovascular disorders, liver disoders, obesity, as an antiinflammatory agent, improving agent of impaired glucose tolerance, insulin resistance and insulin sensitivity
12/06/2007US20070282001 Materials And Methods For Improving Shellfish Health, Immunity And Growth
12/06/2007US20070282000 Triacylglycerol-based alternative to paraffin wax
12/06/2007US20070281999 Alcohol-containing antimicrobial compositions having improved efficacy
12/06/2007US20070281998 Treatment of hot flashes using muscarinic receptor antagonists
12/06/2007US20070281997 Treatment of hot flashes using muscarinic receptor antagonists
12/06/2007US20070281996 Creatine prodrugs, compositions and uses thereof
12/06/2007US20070281995 Creatine analog prodrugs, compositions and uses thereof
12/06/2007US20070281994 Use Of Furan Alkyls For A Cellulite Cosmetic Treatment
12/06/2007US20070281993 Structured Triglycerides And Emulsions Comprising Same
12/06/2007US20070281992 Combination of gyrase b inhibitors and protein synthesis inhibitors and uses thereof
12/06/2007US20070281991 Preparation Of Phenol-Amide Compounds With Anti-Oxidizing Properties
12/06/2007US20070281990 Methods of using low-dose doxepin for the improvement of sleep
12/06/2007US20070281989 Controlling concentration of 2-acetylthiophene; reacting 2-acetylthiophene with polyoxymethylene glycol in presence of a base; batch processing
12/06/2007US20070281988 Combination Therapy for Vascular Complications Associated with Hyperglycemia
12/06/2007US20070281986 Methods and Compositions for Modulating Satiety
12/06/2007US20070281985 Infusion fluid for dialysis patients
12/06/2007US20070281984 Use Of Metronidazole For Preparing A Pharmaceutical Composition For Treating A Cutaneous Inflammation
12/06/2007US20070281983 Creatine analog prodrugs, compositions and uses thereof
12/06/2007US20070281982 crystallilzing anastrozole base, from an aqueous-based solvent containing water and a water soluble solvent selected from dimethyl formamide, dimethyl acetamide, c1-c4 alcohol, and dilute HCl, that contains anastrozol dissolved therein; pharmaceutically acceptable grade of purity
12/06/2007US20070281981 Therapeutic compounds
12/06/2007US20070281980 Polymorphic forms of (S). -tetrahydrofuran-3-yl-3- (3- (3-methoxy-4- (oxazol-5-yl) pheny1) ureido) benzylcarbamate
12/06/2007US20070281979 New FBPase inhibitors for diabetes
12/06/2007US20070281978 Inhibitors of aquaporin 4, methods and uses thereof
12/06/2007US20070281977 antimalarial agent; 3-chloro-6-(hydroxymethyl)-2-methyl-5-[4-({4-[(trifluoromethyl)oxy]phenyl}oxy)phenyl]-4(1H )-pyridinone
12/06/2007US20070281976 Such as 1-(2,6-Dichloro-4-trifluoromethylphenyl)-2,3-dicyano-4-trifluoromethylsulfinyl-5-N-methyl-N-(2-methylthioethyl)aminopyrrole
12/06/2007US20070281975 Tartrate Salt of Isofagomine and Methods of Use
12/06/2007US20070281974 1 h-imidazole derivatives as cannabinoid receptor modulators
12/06/2007US20070281973 such as 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylsulfanyl-N-(pyrrolidin-1-yl)-1H-pyrazole-3-carboxamide, used for the treatment of psychological and nervous system disorders
12/06/2007US20070281972 Pharmaceutical Composition Having Prokinetic Effect
12/06/2007US20070281971 Novel Compound
12/06/2007US20070281970 minimal side effects, selectivity, potency, pharmacokinetics, duration of action; CNS disorders like cognitive, behavioral, mood, autonomic functions; 1-isopropyl-2-oxo-1,2-dihydro-quinoline-3-carboxylic acid {(1S,3R,5R)-8-[3-acetylamino-2-hydroxypropyl]-8-azabicyclo[3.2.1]oct-3-yl}amide
12/06/2007US20070281969 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
1 ... 3470 3471 3472 3473 3474 3475 3476 3477 3478 3479 3480 3481 3482 3483 3484 3485 3486 3487 3488 3489 3490 ... 7860